James River Group (JRVR)
Underwrites specialty casualty insurance and selectively provides admitted insurance and fronting.
Something off on this page? Send us feedback.
Sells specialty property-casualty insurance through excess-and-surplus and specialty-admitted/fronting operations. Makes E&S underwriting its core business while limiting retained risk in specialty-admitted activity after the sale of its casualty-reinsurance operation.
Underwrites excess-and-surplus casualty insurance and runs a specialty-admitted/fronting business. The excess-and-surplus operation is the core focus, while specialty-admitted activity is managed selectively with minimal retained risk.
The group refocused on U.S. insurance and fronting after selling JRG Re, its casualty-reinsurance subsidiary. Its operating priorities include risk management, performance monitoring, underwriting discipline, and expense efficiency. These are explicit management-stated priorities rather than a separate, formally articulated cultural doctrine for the enterprise.
Commercial-auto reserve additions and later loss-portfolio and adverse-development-cover arrangements document how loss development and capital management have shaped the business.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 17, 2026 | UBS | Reiterate | Rating: —Target: $4.75 | Target: $4 |
| May 19, 2026 | UBS | Downgrade | Target: — | Target: $4.75 |
| May 5, 2026 | Citizens | Downgrade | ||
| Mar 3, 2026 | Truist Financial | Target | Target: $5 | Target: $7 |
| Dec 16, 2025 | Raymond James | Target | Target: — | Target: $7 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $835.2M · Total debt $329.9M · Total assets $2.48B · Shareholders' equity $655.7M
- Revenue
- $161.3M
- Operating income
- $14.1M
- Net income
- $6.4M
HistoryDividendAnnual yield
| Institutions | 71.74% | 33.17M shares | |
|---|---|---|---|
| 118 holders · as of Jun 30, 2026 | |||
| Insiders | 16.86% | 7.79M shares | |
| 17 holders · as of Aug 12, 2026 | |||
| Strategic holders | 5.60% | 2.59M shares | |
| 1 holder · as of Nov 13, 2025 | |||
| Other | 5.80% | 2.68M shares | |
| remainder | |||
46.24M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Matthew BoteinInsiderdirector | 12.67% | 5.86M | filed Nov 13, 2024 |
Zimmer Partners, LPInstitution | 10.00% | 4.62M | as of Jun 30, 2026 |
T. Rowe Price Investment Management, Inc.Institution | 9.96% | 4.61M | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 7.34% | 3.39M | as of Jun 30, 2026 |
Continental General Insurance CoInstitution | 5.64% | 2.61M | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- Kinsale Capital Group
Pure-play U.S. E&S insurer for commercial casualty and property
- RLI
Specialty carrier spanning E&S, admitted insurance, and programs
- Skyward Specialty
U.S. specialty P&C carrier across E&S, admitted, and program lines
- W. R. Berkley
Commercial insurer with dedicated nationwide U.S. E&S businesses
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| James River Group | $3.71 | −0.94% | $172.9M | 10.7 | 4.1 | 0.3 | −20.5% |
| Kinsale Capital Group | $348.44 | −0.96% | $8.01B | 14.3 | 16.6 | 4.0 | −3.7% |
| RLI | $57.87 | −0.45% | $5.33B | 12.2 | 21.5 | 2.7 | +16.0% |
| Skyward Specialty | $55.65 | −0.47% | $2.27B | 13.0 | 10.7 | 1.4 | +130.9% |
| W. R. Berkley | $68.30 | +0.19% | $25.38B | 14.0 | 14.4 | 1.4 | +1.2% |
| Median | 13.5 | 15.5 | 2.1 | +8.6% |